Bioxyne Balance Sheet Health
Financial Health criteria checks 3/6
Bioxyne has a total shareholder equity of A$3.3M and total debt of A$36.7K, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are A$6.7M and A$3.4M respectively.
Key information
1.1%
Debt to equity ratio
AU$36.70k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$1.03m |
| Equity | AU$3.30m |
| Total liabilities | AU$3.40m |
| Total assets | AU$6.70m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BXN's short term assets (A$5.6M) exceed its short term liabilities (A$2.9M).
Long Term Liabilities: BXN's short term assets (A$5.6M) exceed its long term liabilities (A$490.7K).
Debt to Equity History and Analysis
Debt Level: BXN has more cash than its total debt.
Reducing Debt: BXN's debt to equity ratio has increased from 0% to 1.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BXN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BXN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.3% each year